iTeos Therapeutics (ITOS) Earnings Date, Estimates & Call Transcripts → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free ITOS Stock Alerts $18.05 +0.15 (+0.84%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (Mar. 6) -$0.85 Beat By $0.18 Consensus EPS (Mar. 6) -$1.03 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueITOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ITOS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. iTeos Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($1.22)($0.89)($1.06)Q2 20242($1.15)($0.99)($1.07)Q3 20242($1.21)($1.11)($1.16)Q4 20242($1.25)($1.24)($1.25)FY 20248($4.83)($4.23)($4.53)Q1 20251($1.40)($1.40)($1.40)Q2 20251($1.52)($1.52)($1.52)Q3 20251($1.64)($1.64)($1.64)Q4 20251($1.78)($1.78)($1.78)FY 20254($6.34)($6.34)($6.34)ITOS Earnings Date and InformationiTeos Therapeutics last issued its quarterly earnings results on March 6th, 2024. The reported ($0.85) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.03) by $0.18. iTeos Therapeutics has generated ($3.78) earnings per share over the last year (($3.78) diluted earnings per share). Earnings for iTeos Therapeutics are expected to decrease in the coming year, from ($4.57) to ($5.76) per share. iTeos Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More iTeos Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 3/6/2024Q4 2023($1.03)($0.85)+$0.18($0.85)$37.41 million-11/7/2023Q3 2023($1.20)($0.90)+$0.30($0.90)--8/8/2023Q2 2023($1.03)($0.96)+$0.07($0.96)--5/10/2023Q1 2023($0.99)($0.44)+$0.55($0.44)$13.80 million$12.60 million3/15/2023Q4 2022$0.42$0.57+$0.15$0.57$41.16 million$53.91 million11/10/2022Q3 2022$0.07$0.03($0.04)$0.03$42.05 million$19.49 millionCrypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos…8/10/2022Q2 2022$1.20$0.15($1.05)$0.15$96.95 million$41.72 million5/12/2022Q1 2022$0.80$1.82+$1.02$1.82$63.30 million$152.52 million 3/23/2022Q4 2021$1.29$4.88+$3.59$4.88$85.45 million$240.50 million11/10/2021Q3 2021$4.95$1.86($3.09)$1.86$329.75 million$104.27 million 8/12/2021Q2 2021($0.41)($0.75)($0.34)($0.75)-- iTeos Therapeutics Earnings - Frequently Asked Questions When is iTeos Therapeutics's earnings date? iTeos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on ITOS's earnings history. Did iTeos Therapeutics beat their earnings estimates last quarter? In the previous quarter, iTeos Therapeutics (NASDAQ:ITOS) reported ($0.85) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.03) by $0.18. Learn more on analysts' earnings estimate vs. ITOS's actual earnings. How much revenue does iTeos Therapeutics generate each year? iTeos Therapeutics (NASDAQ:ITOS) has a recorded annual revenue of $12.60 million. How much profit does iTeos Therapeutics generate each year? iTeos Therapeutics (NASDAQ:ITOS) has a recorded net income of -$112.64 million. ITOS has generated -$3.78 earnings per share over the last four quarters. What is iTeos Therapeutics's EPS forecast for next year? iTeos Therapeutics's earnings are expected to decrease from ($4.57) per share to ($5.76) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Lexeo Therapeutics Earnings Fate Therapeutics Earnings Alvotech Earnings Adaptive Biotechnologies Earnings Replimune Group Earnings Taysha Gene Therapies Earnings Editas Medicine Earnings C4 Therapeutics Earnings TScan Therapeutics Earnings Voyager Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:ITOS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist My Default Watchlist Adding iTeos Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.